Orciprenaline
生产企业：Boehringer ingelheim pharmaceuticals inc, Astrazeneca lp，另有 14 家
Orciprenaline is a beta-2 adrenergic agonist used to treat bronchospasm, asthma, and COPD.
Orciprenaline is a beta-2 adrenergic agonist used to treat bronchospasm, asthma, and COPD.
Orciprenaline stimulates the β2-adrenergic receptor expressed in the lungs, uterus, and vasculature supplying skeletal muscles by acting as a moderately selective agonist. It exerts minimal or no effect on alpha-adrenergic receptors. Intracellularly, the actions of orciprenaline are mediated by cAMP, the production of which is augmented by beta stimulation. The drug is believed to work by activating adenylate cyclase, the enzyme responsible for producing the cellular mediator cAMP.
用于支气管哮喘和哮喘型支气管炎、慢性阻塞性肺病所致支气管痉挛。亦可静脉滴注用于房室传导阻滞。
每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。
